FDA warned on insertion of drugs directly acting on incretins, several cases of pancreatitis were observed in postmarketing analysis but it should be noted that patients with hyperglycemia and T2DM are risked of pancreatitis [68]. This evidence concerns the gene GCG and type 2 diabetes mellitus.